2Dynamic ensembles that capture the flexibility of RNA three-dimensional (3D) structures hold great promise in advancing RNA-targeted drug discovery. Here, we experimentally screened the transactivation response element (TAR) RNA from human immunodeficiency virus type-1 (HIV-1) against ~100,000 small molecules. We used this dataset, along with 240 known hit molecules, to evaluate virtual screening (VS) against a high-resolution TAR ensemble determined by combining NMR spectroscopy and molecular dynamics (MD) simulations. Ensemble-based VS (EBVS) scores molecules with an area under the receiver operator characteristic curve (ROC AUC) of 0.87 with ~50% of all hits falling within the top 2% of scored molecules, and also correctly predicts the different TAR inter-helical structures when bound to six molecules. The prediction accuracy decreased significantly with decreasing accuracy of the target ensemble or when docking against a single RNA structure. These results demonstrate that experimentally determined ensembles can significantly enrich libraries with structure-specific RNA binders as well as motivate the continued development of methods for improving ensemble accuracy.Accompanying the non-coding RNA (ncRNA) revolution has been growing interest in RNA as a drug target, particularly for diseases that do not have suitable protein targets [1][2][3][4][5][6] . The growing list of ncRNA targets now includes microRNAs, long ncRNAs, repetitive RNA transcripts, riboswitches, and viral RNAs. Much attention has been directed towards targeting ncRNAs with small molecules, which do not suffer from the inherent delivery limitations associated with oligonucleotide-based therapeutics, and which can be tailored to specifically target the diverse 3D structures of RNA 2-5 . There are, however, fundamental challenges in targeting RNA using small molecules [4][5][6][7] . Libraries used in highthroughput screening (HTS) are optimized for the deep, hydrophobic pockets of protein targets and not the more polar and solvent exposed pockets typical of RNA targets 7 . Screens targeting ncRNAs typically yield very few hit molecules most of which show little discrimination against other cellular RNAs, have unfavorable pharmacological properties, and poor activity in cell-based assays. Rational . CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/151407 doi: bioRxiv preprint first posted online 3 approaches to identify small molecules that bind specific RNA secondary structure have had some 19,20 . EBVS was able to score a small set of 38 known TAR binders with an accuracy comparable to that obtained when docking 48 small molecules to their known bound RNA structure 9 . Experimentally testing the top 57 scoring small molecules out of a screen of 51,000 compounds yielded six hit molecules that bind TAR in vitro, including the first example of a small molecule that binds an RNA apical loop, and a highly ...